Gut Microbiome Intervention With EXL01 in Combination With Nivolumab and FOLFOX as First-line Treatment for Patients With PD-L1 CPS ≥5 Metastatic Gastric Cancer: A Randomized GERCOR Phase II Study (BIG)
Latest Information Update: 29 Jul 2024
At a glance
Most Recent Events
- 25 Jul 2024 Status changed from not yet recruiting to recruiting.
- 15 Feb 2024 New trial record